Zhejiang Hisoar Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 4 molecules.
| Site | FDA FEI |
|---|---|
| Taizhou, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Clindamycin | SFDA (Saudi Arabia), US FDA | 4 |
| Amorolfine | EDQM, SFDA (Saudi Arabia) | 2 |
| Flunixin Meglumine For Veterinary Use | EDQM | 1 |
| Metoprolol | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Zhejiang Hisoar Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free